Copyright Reports & Markets. All rights reserved.

Global Rosacea Treatments Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Rosacea Treatments Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Topical
      • 1.4.3 Orals
    • 1.5 Market by Application
      • 1.5.1 Global Rosacea Treatments Market Share by Application (2014-2025)
      • 1.5.2 Drugs Stores
      • 1.5.3 Hospital
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Rosacea Treatments Market Size
    • 2.2 Rosacea Treatments Growth Trends by Regions
      • 2.2.1 Rosacea Treatments Market Size by Regions (2014-2025)
      • 2.2.2 Rosacea Treatments Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Rosacea Treatments Market Size by Manufacturers
      • 3.1.1 Global Rosacea Treatments Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Rosacea Treatments Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Rosacea Treatments Market Concentration Ratio (CR5 and HHI)
    • 3.2 Rosacea Treatments Key Players Head office and Area Served
    • 3.3 Key Players Rosacea Treatments Product/Solution/Service
    • 3.4 Date of Enter into Rosacea Treatments Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Rosacea Treatments Market Size by Type (2014-2019)
    • 4.2 Global Rosacea Treatments Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Rosacea Treatments Market Size (2014-2019)
    • 5.2 Rosacea Treatments Key Players in United States
    • 5.3 United States Rosacea Treatments Market Size by Type
    • 5.4 United States Rosacea Treatments Market Size by Application

    6 Europe

    • 6.1 Europe Rosacea Treatments Market Size (2014-2019)
    • 6.2 Rosacea Treatments Key Players in Europe
    • 6.3 Europe Rosacea Treatments Market Size by Type
    • 6.4 Europe Rosacea Treatments Market Size by Application

    7 China

    • 7.1 China Rosacea Treatments Market Size (2014-2019)
    • 7.2 Rosacea Treatments Key Players in China
    • 7.3 China Rosacea Treatments Market Size by Type
    • 7.4 China Rosacea Treatments Market Size by Application

    8 Japan

    • 8.1 Japan Rosacea Treatments Market Size (2014-2019)
    • 8.2 Rosacea Treatments Key Players in Japan
    • 8.3 Japan Rosacea Treatments Market Size by Type
    • 8.4 Japan Rosacea Treatments Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Rosacea Treatments Market Size (2014-2019)
    • 9.2 Rosacea Treatments Key Players in Southeast Asia
    • 9.3 Southeast Asia Rosacea Treatments Market Size by Type
    • 9.4 Southeast Asia Rosacea Treatments Market Size by Application

    10 India

    • 10.1 India Rosacea Treatments Market Size (2014-2019)
    • 10.2 Rosacea Treatments Key Players in India
    • 10.3 India Rosacea Treatments Market Size by Type
    • 10.4 India Rosacea Treatments Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Rosacea Treatments Market Size (2014-2019)
    • 11.2 Rosacea Treatments Key Players in Central & South America
    • 11.3 Central & South America Rosacea Treatments Market Size by Type
    • 11.4 Central & South America Rosacea Treatments Market Size by Application

    12 International Players Profiles

    • 12.1 Nestle Skin Health
      • 12.1.1 Nestle Skin Health Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Rosacea Treatments Introduction
      • 12.1.4 Nestle Skin Health Revenue in Rosacea Treatments Business (2014-2019)
      • 12.1.5 Nestle Skin Health Recent Development
    • 12.2 Teva
      • 12.2.1 Teva Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Rosacea Treatments Introduction
      • 12.2.4 Teva Revenue in Rosacea Treatments Business (2014-2019)
      • 12.2.5 Teva Recent Development
    • 12.3 Mylan
      • 12.3.1 Mylan Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Rosacea Treatments Introduction
      • 12.3.4 Mylan Revenue in Rosacea Treatments Business (2014-2019)
      • 12.3.5 Mylan Recent Development
    • 12.4 Bayer
      • 12.4.1 Bayer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Rosacea Treatments Introduction
      • 12.4.4 Bayer Revenue in Rosacea Treatments Business (2014-2019)
      • 12.4.5 Bayer Recent Development
    • 12.5 Sun Pharma
      • 12.5.1 Sun Pharma Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Rosacea Treatments Introduction
      • 12.5.4 Sun Pharma Revenue in Rosacea Treatments Business (2014-2019)
      • 12.5.5 Sun Pharma Recent Development
    • 12.6 Perrigo
      • 12.6.1 Perrigo Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Rosacea Treatments Introduction
      • 12.6.4 Perrigo Revenue in Rosacea Treatments Business (2014-2019)
      • 12.6.5 Perrigo Recent Development
    • 12.7 Bausch Health
      • 12.7.1 Bausch Health Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Rosacea Treatments Introduction
      • 12.7.4 Bausch Health Revenue in Rosacea Treatments Business (2014-2019)
      • 12.7.5 Bausch Health Recent Development
    • 12.8 GSK
      • 12.8.1 GSK Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Rosacea Treatments Introduction
      • 12.8.4 GSK Revenue in Rosacea Treatments Business (2014-2019)
      • 12.8.5 GSK Recent Development
    • 12.9 Pfizer
      • 12.9.1 Pfizer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Rosacea Treatments Introduction
      • 12.9.4 Pfizer Revenue in Rosacea Treatments Business (2014-2019)
      • 12.9.5 Pfizer Recent Development
    • 12.10 Allergan
      • 12.10.1 Allergan Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Rosacea Treatments Introduction
      • 12.10.4 Allergan Revenue in Rosacea Treatments Business (2014-2019)
      • 12.10.5 Allergan Recent Development
    • 12.11 Almirall

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Rosacea is a common skin condition characterized by redness and visible blood vessels on the face. The nose and cheeks are the most affected regions. The signs and symptoms of Rosacea are small, red, pus-filled bumps which may flare up periodically. About half the patients experience eye dryness, irritation and swollen, reddened eyelids. Other symptoms include enlarged nose, thickening the skin on the nose, (rhinophyma). Rosacea predominantly affects middle-aged women having fair skin.
      Americas is the largest consumption place, with a consumption market share nearly 62.2% in 2017. Following Americas, Europe is the second largest consumption place with the consumption market share of 24.4% in 2017
      In 2018, the global Rosacea Treatments market size was 1430 million US$ and it is expected to reach 1790 million US$ by the end of 2025, with a CAGR of 3.2% during 2019-2025.

      This report focuses on the global Rosacea Treatments status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rosacea Treatments development in United States, Europe and China.

      The key players covered in this study
      Nestle Skin Health
      Teva
      Mylan
      Bayer
      Sun Pharma
      Perrigo
      Bausch Health
      GSK
      Pfizer
      Allergan
      Almirall

      Market segment by Type, the product can be split into
      Topical
      Orals

      Market segment by Application, split into
      Drugs Stores
      Hospital
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Rosacea Treatments status, future forecast, growth opportunity, key market and key players.
      To present the Rosacea Treatments development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Rosacea Treatments are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now